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Abstract
Background: It has been shown that the clinical state of one patient can be represented by known measured variables of
interest, each of which then form the element of a fuzzy set as point in the unit hypercube. We hypothesized that precise
comparison of a single patient with the average patient of a large double blind controlled randomized study is possible
using fuzzy theory.
Methods/Principle Findings: The sets as points unit hypercube geometry allows fuzzy subsethood to define in measures of
fuzzy cardinality different conditions, similarity and comparison between fuzzy sets. A fuzzy measure of prediction is defined
from fuzzy measures of similarity and comparison. It is a measure of the degree to which fuzzy set A is similar to fuzzy set B
when different conditions are taken into account and removed from the comparison. When represented as a fuzzy set as
point in the unit hypercube, a clinical patient can be compared to an average patient of a large group study in a precise
manner. This comparison is expressed by the fuzzy prediction measure. This measure in itself is not a probability. Once thus
precisely matched to the average patient of a large group study, risk reduction is calculated by multiplying the measured
similarity of the clinical patient to the risk of the average trial patient.
Conclusion/Significance: Otherwise not precisely translatable to the single case, the result of group statistics can be applied
to the single case through the use of fuzzy subsethood and measured in fuzzy cardinality. This measure is an alternative to a
Bayesian or other probability based statistical approach.
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Introduction
Physicians make diagnostic and treatment decisions based on
their perception of how scientific evidence matches the clinical
patient in question. This perception and decision are inscrutable,
often requiring different degrees of expertise. Before the advent of
The Generalized Theory of Uncertainty (GTU) developed by
Lotfi Zadeh, precise representation and calculation with percep-
tions expressed in natural language had been impossible. [1]
Precise presentation of the way in which physicians perceive a
patient’s condition and make clinical decisions requires represen-
tation of the human cognitive skills of graduation and granulation
in such form as computation might take place. This representation
is satisfied by the tools of fuzzy logic and GTU. [1] Information
can now be expressed in non statistical form. [1] This is quite
different from information gained from large double blind
randomized clinical trails which is statistical in form, based in
bivalent Aristotelian logic and probability theory.
Fuzzy theory admits everything to be present to a degree. Thus,
when considering the physiologic or pathologic elements of a
patient, those elements can each be given a value in the unit
interval without constraint on nor being constrained by the value
of the others in order to form the element of a fuzzy set. [2]
Numerical valuation for any element of clinical interest is achieved
through laboratory measurement and normalization or through
expert assignment. The advantage to representing the patient’s
clinical state defined by the elements in a fuzzy set is that no value
of any element is constrained by those of any other. This property
of fuzzy logic also allows overlap of value assignment in a fuzzy
graph or granulation.
We have described how the fuzzy ‘‘sets as points’’ representation
of a patient’s clinical state in the unit hypercube allows for the
visualization, demonstration and ultimate measurement of the
different conditions of each fuzzy set as point. [3,4] Those
conditions are by their nature, symmetries of fuzzy cardinality of
all the other fuzzy sets as points in the unit hypercube. A measure
for different degrees of symmetry breaking and restoration of new
symmetry of conditions has been defined by us and called ‘‘K’’. [4]
This measure provides a means to precisely represent the
difference in conditions of any two patients.
Scientific medicine demands that in order for two patients to be
compared their conditions must be no different. This is the same
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conditions remain unchanged. For this reason scientific medicine
relies on statistics based in probability theory. In this study we
show how one unique patient can be compared to the average
patient of a large double blind controlled randomized trial in a
precise and measurable fashion using fuzzy theory. This method is
an alternative to the Bayesian approach of ‘‘Evidence-Based
Medicine’’ founded in probability theory. It is by its very nature of
foundation in fuzzy theory different from other probability based
statistical approaches.
Results
The calculation of risk reduction for a clinical patient presenting
to the physician, B, compared to the risk reduction for the average
study patient, A, of a chosen large double randomized controlled
clinical trial, the Caprie Study, is given by the following using the
clinical information provided in the materials and methods section
of this paper:
A={0.5, 0.5} and B={0.7, 0.6}, where fuzzy sets as points A
and B represent patient A and patient B, and fuzzy set elements
are time since stroke and time on study drug normalized to fall
within the unit interval.
F Sim ( A, B) ~ M f 0:5, 0:5 g=1zvf 0:5, 0:5 g=1:3
~1z0:7
~1:7
K=1.49, where K is the measure of breaking symmetry of
conditions
F Comp ( A, B )~1:7   (1 :49   1)
~1:7   0:49
~1:21
F Pred ( A, B )~1:21=1:7
~0:71
The overall risk reduction for vascular mortality and ischemic
stroke in the Caprie study in favor of clopidogrel compared to
aspirin was 8.7%. Our patient has benefited from clopidogrel by
6.18% as measured by F Pred (A, B) for our patient compared to
the average patient of the Caprie study, or 0.7168.7=6.18%.
Results of the average patient form a large double blind controlled
randomized trial, the Caprie study, can be measurably adapted to
the single patient at the bedside to calculate the risk reduction for
clopidogrel. The hypothesis that fuzzy measures can achieve this is
proven true. Our hypothetical patient has had a 6.18% risk
reduction for vascular mortality and ischemic stroke compared to
if he/she had been on aspirin.
Other results of the Caprie study can also be applied to this
patient. The risk reduction for the average Caprie study patient for
all cause mortality and all cause strokes was 6.9% for those
patients taking clopidogrel. For our clinical patient his/her overall
risk reduction for these parameters is 0.7166.9, or 4.90%. Now
had the patient inquired, well what are my ‘‘chances’’ of having an
ischemic stroke if I am on aspirin? The primary analysis of
outcome in the Caprie study showed that 4.8% of patients on
aspirin had an ischemic stroke. We use our same numbers for
comparison of our patient to the average patient of the trial,
because these do not change, but now we multiply our fuzzy
prediction measure by 4.8% and get 0.7164.8 to get 3.4% and if
on clopidogrel 0.7164.6 to get 3.27%; of having a myocardial
infarction on aspirin 0.7163.5% or 2.49% for aspirin versus
0.7162.06% or 1.46% if on clopidogrel.
In this study we did not use the fuzzy entropy measures of
similarity and symmetry because the problem at hand, to compare
the outcomes of the average patient in the Caprie study to our
hypothetical bedside patient did not require so.
Discussion
We defined several fuzzy measures for comparison of individual
fuzzy ‘‘sets as points’’ in the unit hypercube. [5,7] The geometric
structure of the unit hypercube and sets as points representation
was chosen in order to develop these measures from the fuzzy
subsethood theorem, and the fuzzy entropy theorem, measured in
fuzzy cardinality. [7] Of particular interest was the ability to
compare fuzzy sets as points not only by the values of their
elements, but as to their different conditions. These conditions are
all the surrounding fuzzy sets as points in the unit hypercube, each
of which has a known fuzzy cardinality. A fuzzy measure of
breaking of symmetry of conditions, called ‘‘K’’, defined from
fuzzy subsethood and measured in fuzzy cardinality was employed
for this purpose. [4] A demonstration of K exists when two fuzzy
sets are exchanged in the unit hypercube. If considered a ball of
certain size defined by fuzzy cardinality, the exchange of two such
fuzzy sets as points disturbs the position of all the others, if the
exchange takes place between two fuzzy sets as points of different
size. Without the fuzzy sets as points geometry in the unit
hypercube, the changing symmetry of conditions would not be
demonstrable in this fashion. [3] We have elsewhere demonstrated
the symmetry breaking property of K using continuous cellular
automata where K is the multiplicative factor and 1/K the initial
seed. [8]
In this paper, the reason for comparing two fuzzy sets as points
in the unit hypercube was to develop a means of prediction for the
single case. Herein, the single case is a patient. We focused on the
problem posed to the medical physician in opining diagnosis and
treatment when such decisions are to be ‘‘scientifically’’ based.
The problem is two fold. On the one hand, physician decisions
based on expertise are considered vague and ambiguous, and for
this reason unscientific. On the other hand, in response to this fact,
medical science has adopted the stance that physician decisions
should be based on the results of large double blind controlled
randomized clinical trials.[9] This is because these trials are based
in probability theory and promise certainty in their results. This
certainty rests on the property of uniform conditions. These
uniform conditions can be demonstrated in the unit hypercube
within the probability space. [5] The physician however must
make his match of patient to average patient of the clinical trial all
while considering the different conditions of the two.
We have previously noted that the decision of how to apply and
adapt the results of these trials to the individual clinical patient
depends on the physician’s ability to match the trial results to that
patient. This matching process requires cognitive skill that in itself
is inscrutable because no individual patient has the same
conditions or context as those possessed by the average patient
of the large group trial. Conditions or context refer to all those
unknown unmeasured elements that might affect the clinical
behavior or outcome of the patient. These conditions are assumed
to be uniform in the large double blind randomized clinical trial,
but in reality can never all be accounted for in any population of
Fuzzy Measures of Prediction
PLoS ONE | www.plosone.org 2 April 2008 | Volume 3 | Issue 4 | e1909different individuals. This is demonstrable in the unit hypercube
outside of the probability space where known measured element
values of each fuzzy set as point are not constrained by their sum
always being certain. Evidence based medicine can use a pooled
analysis based on data from clinical trials and applies the model to
the patient. This results in a probability measure of estimated risks
for the single patient based on his known measured elements. [9]
Different unknown conditions remain unaccounted for in their
role of how accurate the prediction based on probabilities turns
out to be for that patient.
In general, the process of diagnosis and treatment requires the
cognitive skills of graduation and granulation, both capable of
precise representation within the GTU. The fuzzy measure of
breaking of symmetry of conditions allows for a quantitative
representation of different conditions of different patients, thus
allowing an exact match to be measured between any patient and
the average patient of a clinical trial. We propose that this process
can be used as a step in the process of computing measured risk for
the single patient based on results of clinical trials. This step takes
into account the difference in the degree of presence of each
clinically relevant factor as well their different conditions.
While Bayes’ theorem is one basis for making scientific clinical
decisions at the bedside, it does not give the same measure as we
have developed in this paper with the fuzzy prediction measure.
The Bayesian approach allows the physician to know the
probability that a study applies to a given clinical patient who
has certain known measured elements, but this is followed by an
intuitive stance on the part of the physician in applying the results
of the clinical trial to the unique patient facing him. [7] This is
because that unique patient has his own personal unique context
or conditions, which are different from those of the average patient
of the clinical trial. The fuzzy prediction measure used in our study
gives an exact translation of study results to the individual patient,
with no room for chance in that match to the average patient of
the trial.
We proposed that instead of relying on probability theory and
statistical information, fuzzy theory within the general context of
GTU may solve the problems posed in representing bedside
clinical information and physician decision. [1] The standard
fashion of applying the results of a large clinical trial to an
individual patient requires building a statistical model using trial
data and applying the model to the patient according to known
measured risk factors of that patient. [9] This method, while
elegant, does not account for the different conditions of the patient
that are not accounted for by known measured variables. It
assumes that unknown factors are present, but somehow their
effect on the known measured variables cancels out. It also
provides information in the form of a probability. Because it is
founded on probabilities it is fundamentally different from the
fuzzy prediction measure which does not rely on bivalent
Aristotelian logic nor assume uniform conditions in the compar-
ison between the clinical patient and those of the trial.
We have shown in a previous paper that measures of
comparison for two single patients can easily be defined using
fuzzy subsethood and entropy. [5] This is because fuzzy theory is
able to account in a measurable way for different conditions of
different individual patients. These conditions can be demonstrat-
ed in the unit hypercube as having a symmetry that can be broken
and restored to a certain degree when one fuzzy set as point is
compared or transforms to another. In the instance of following
one patient over time at different clinical states, each state
represented by known measured variables of interest and as fuzzy
sets as points in the unit hypercube can be said to transform to
another. This transformation or comparison between fuzzy sets as
points in the unit hypercube involves a dynamic where symmetry
breaking and restoration to a degree of conditions and a
subsethood relation of known measured variables characterizes
the action.
In this study we are able to show that the fundamental concept
of fuzzy theory, subsethood, and its primary measure space, fuzzy
cardinality as instantiated in the fuzzy unit hypercube can be
employed to give a precise and measurable match of the single
clinical patient to the average patient of any large double blind
randomized clinical trial. This ability has the potential to render
precise physician decisions at the bedside and gives new relevance
to the results of clinical trials. We intend to test this hypothesis by
taking the results of a large double blind randomized controlled
clinical trial, the AAASPS ( African American Antiplatelet Stroke
Prevention Study) trial, and compare each patient in that trial to
the average patient of the trial using the fuzzy prediction measure.
This comparison will test the predictive capacity of the fuzzy
prediction measure for each patient in the trial because the
outcome of each patient is already known from the trial results.
[10].
Materials and Methods
Medical science has relied on probability theory and the large
double blind controlled randomized clinical trial in order to
guarantee certainty in the calculation of the relation of known
measured variables without interference of different conditions.
We have shown that different conditions of different patients can
be measured by the symmetry breaking measure ‘‘K’’ as two fuzzy
sets as points in a unit hypercube, representing two different
patients A and B, are compared. [4]
The measure K and the measure of fuzzy similarity of two fuzzy
sets as points in the unit hypercube (F Sim (A, B)) are derived from
fuzzy subsethood and the primary measure space of fuzzy theory
fuzzy cardinality. This measure allows two sets as points in a unit
hypercube to be compared precisely while accounting for different
conditions.
We hypothesized that the fuzzy measure of prediction ( F Pred
(A,B)) defined by us using fuzzy subsethood and measured in fuzzy
cardinality can be used to precisely compare an individual clinical
patient to the average patient of a large double blind randomized
controlled clinical trial. [5]
Every large double blind randomized controlled clinical study
has the concept of an average patient. The concept of average
enforces symmetry of conditions in a statistical sense. We take the
results of such a large group clinical study call the Caprie Study.
The average patient in this study took an antiplatelet agent
clopidogrel 75 mg daily or aspirin 325 mg daily for a period of
1.6 years. Randomization required having suffered an ischemic
stroke within 6 months of randomization. When faced with the
clinical patient, the physician wants to be able to predict for any
patient taking clopidogrel under similar circumstances the effect of
clopidogrel or aspirin on that patient’s outcome.
The overall risk reduction for vascular mortality and ischemic
stroke in the Caprie study was in favor of clopidogrel by 8.7%. [6]
We take the example of a hypothetical patient. The patient in
question had a stroke 9 months before he started his clopidogrel
and has now been taking it for 2 years. How much ash clopidogrel
reduced his risk compared to if he had been on aspirin? For the
purpose of testing our hypothesis we use the example of this
hypothetical patient and assume that time from stroke onset was
6 months for the average patient in the Caprie study.
The average patient A of the Caprie study and our patient B are
compared using our definition of fuzzy similarity and fuzzy
Fuzzy Measures of Prediction
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of prediction tells the physician how much A is equal to B given
their different conditions. It is expressed by F Comp (A, B)/F Sim
(A, B). Given the known elements of time from stroke and time on
medication, we can represent the average patient from the Caprie
study and the clinical patient presenting to the physician by these
elements where each patient is represented as a fuzzy set as point
in the unit hypercube. After normalization of time since stroke by
12 (months) and time on study drug by 3 (years) each element falls
within the unit interval. The average patient from the Caprie study
can be represented as fuzzy set A { 0.5,0.5 } and the clinical
patient B { 0.7,0.6 }.
The F Sim ( A , B ) and F Comp ( A, B ) measures are calculated
using the definition of F Sim (A,B )=S ( A,B )+S ( B, A ) , where S
stands for fuzzy subsethood . Fuzzy subsethood of A in B is the
degree to which fuzzy set as point A belongs to fuzzy set as point B.
The fuzzy measure of comparison F Comp ( A, B )=F Sim ( A,B )
– (K-1) , where K is the fuzzy measure of symmetry breaking of
conditions previously defined by us from the fuzzy subsethood
theorem and measured in fuzzy cardinality. The number 1 is the
value of K for every exchange of fuzzy sets as points in the unit
hypercube probability space. The resulting fuzzy prediction
measure F Comp ( A,B )/F Sim ( A,B ) is multiplied by the risk
reduction for the average patient of the Caprie study to find the
predicted risk reduction for the clinical patient at hand.
The following definitions are those used in the computation of
our fuzzy measure of prediction:
K~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ




MA \B ðÞ =MB ðÞ
p
MA \B ðÞ =MB ðÞ ðÞ 2| MA \B ðÞ =MB ðÞ ðÞ 2
Where K is the fuzzy measure of breaking symmetry of conditions.
Like K, 1/K changes symmetry of conditions in the sense that it
restores them to a degree. The measures K and 1/K characterize
the transformation of fuzzy set as point A to fuzzy set as point B in
the unit hypercube. Transformation is another word for ‘‘changes
into’’ or comparison. It involves the action of element value
change and symmetry of conditions change.
F Sim (A,B) , F Comp (A,B ) and F Pred (A,B ) are already
defined in the above discussion. In the F Comp ( A,B ) expression, (
K-1) stands for the subtraction of all change in symmetry of
conditions minus that change which does not take place in the
probability space within the unit hypercube.
E Sim ( A , B ) stands for the fuzzy entropy of similarity of fuzzy
sets as points A and B. It is a measure of the indistinguishability or
fuzzy equality of F Sim ( A , B) and F Comp ( A , B ). It is defined
by the fuzzy entropy theorem. It is otherwise expressed as E ( F
Sim ( A, B ), F Comp ( A, B ). [7]
In this paper we do not use this measure. It is another way of
comparing the similarity of fuzzy sets as points A and B when
different conditions are not accounted for ( F Sim ( A,B ) and when
they are accounted for ( F Comp ( A , B )). [7] It is a useful measure
for comparing two patient groups during the conduct of a clinical
trial using fuzzy measures of comparison. [5] It is also useful for
comparing the different states of one patient over time at serial
measures.
E Symm ( A , B ) stands for the entropy of symmetry, and it is
another way of measuring the degree to which the breaking and
restoration of symmetry of conditions are equal. It is otherwise
expressed as E ( K , 1/K ). This measure is not used in this paper.
It is also a useful measure when comparing patients and controls in
a clinical trial. It is also useful for comparing the different states of
one patient as they are measured at different points over time.
Author Contributions
Conceived and designed the experiments: CH TJ. Performed the
experiments: TJ. Wrote the paper: CH TJ.
References
1. Zadeh LA (2006) Generalized theory of uncertainty ( GTU) –principle concepts
and ideas. Computational Statistics and Data Analysis 51: 15–46.
2. Zadeh LA (1965) Fuzzy sets. Information & Control 8: 338–353.
3. Helgason CM, Jobe TH (2007) Stroke is a dynamic process best captured using a
fuzzy logic based scientific approach to information and causation. IC Med ( TSI
Press) 1: 5–9.
4. Helgason CM, Jobe TH (2003) Perception based reasoning and fuzzy cardinality
provide direct measures of causality sensitive to initial conditions of the
individual stroke patient. International journal for computational cognition 1:
74–104.
5. Helgason CM, Jobe TH (2007) Fuzzy measures of symmetry breaking of
conditions, similarity and comparison. Non statistical information for the single
patient. Open Access Cybernetics & Systemics Journal ( Bentham Science) 2:
11–19.
6. Nickman NA, Biskupiak J, Creekmore F, Shah H, Brixner DI (2007) Antiplatelet
medication management in patients hospitalized with ischemic stroke. American
Journal Health Syst. Pharm 64: 2250–2256.
7. Kosko B (1993) Neural networks and fuzzy systems. A dynamical approach to
machine intelligence. Englewood CliffsNJ: Prentice Hall, Inc. 07632: 2018,
263–296.
8. Helgason CM, Jobe TH (2005) Fuzzy logic and continuous cellular automata in
warfarin dosing of stroke patients. Current Treatment Options in Cardiovas-
cular Medicine 7: 211–215.
9. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, et al. (2004) Pooled
analysis of fluoruracil-based adjuvant therapy for Stage II and III colon cancer:
Who benefits and by how much? Clin Oncol 22: 1797–1806.
10. Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, et al. (2003) , for the
Aftrican American Antiplatelet Stroke Prevention Study ( AAASPS) (2003)
Aspirin and ticlopidine for prevention of recurrent stroke in black patients. A
randomized trial. JAMA 289: 2947–2957.
Fuzzy Measures of Prediction
PLoS ONE | www.plosone.org 4 April 2008 | Volume 3 | Issue 4 | e1909